Engagement between TAM‐derived TGF‐β with its receptor on breast cancer cells inhibits STAT1 transcription and reduces succinate dehydrogenase, which result in the accumulation of succinate in tumour cells. The gene discussed is TGFB1; the disease is breast carcinoma.